Amniotic and Placental-Derived Product Injections and/or Applications for Musculoskeletal Indications, Non-Wound
JE · Effective Nov 12, 2023
32 active Medicare policies list M87.051, and 5 commercial payer policies list it. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
JE · Effective Nov 12, 2023
JF · Effective Nov 12, 2023
JJ · Effective Apr 30, 2023
JM · Effective Apr 30, 2023
JH · Effective Oct 1, 2015
JL · Effective Oct 1, 2015
J9 · Effective Oct 1, 2015
JE · Effective Oct 1, 2015
5 policies from 1 payer
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
| Policy | Effective | Status of M87.051 |
|---|---|---|
| Allograft Transplants of the Extremities | Nov 20, 2023 | Covered |
| Autologous Skeletal Myoblast/Mononuclear Bone Marrow Cell Transplantation | Aug 30, 2023 | Covered |
| Blood and Adipose Tissue Derived Products for Selected Indications | Oct 26, 2023 | Covered |
| Core Decompression for Avascular Necrosis | Oct 4, 2023 | Covered |
| Magnetic Resonance Imaging (MRI) of the Extremities | Apr 6, 2023 | Covered |
JF · Effective Oct 1, 2015
J15 · Effective Mar 15, 2026
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
J5 · Effective Oct 13, 2024
J8 · Effective Oct 13, 2024
JE · Effective Sep 7, 2016
JF · Effective Sep 7, 2016
National · Effective Oct 1, 2026
National · Effective Oct 1, 2026
J6 · Effective Oct 1, 2026
National · Effective Oct 1, 2025
J5 · Effective Oct 1, 2026
J9 · Effective Jan 1, 2026
JL · Effective Jan 1, 2026
National · Effective Oct 1, 2026
JL · Effective Jan 1, 2026
J9 · Effective Jun 25, 2026
National · Effective Oct 1, 2026
National · Effective Nov 6, 2025
National · Effective Jan 1, 2026
J5 · Effective Aug 27, 2026
National · Effective Mar 15, 2026
National · Effective Jan 1, 2026